Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of Brooklyn ImmunoTherapeutics stock opened at $1.56 on Friday. The firm has a fifty day moving average price of $1.83 and […]

Related Keywords

Brooklyn Immunotherapeutics ,Renaissance Technologies ,Brooklyn Immunotherapeutics Inc ,Eterna Therapeutics Inc ,Securities Exchange Commission ,Brooklyn Immunotherapeutics Company Profile ,Free Report ,Get Free Report ,Nyse Btx ,Kbtx ,Information ,Initiated Coverage ,Stocknews Com ,